How Will Biotech ETFs React To These Q4 Earnings Releases?

Medic, Hospital, Laboratory, Medical, Health, Doctor

The coronavirus outbreak is aggravating in the United States and globally, with the number of infected cases increasing. Thus, any positive news highlighting the progress of vaccine developers or antibody manufacturers is expected to create great returns for investors.

The pandemic has also a triggered a race to introduce vaccine and treatment, thereby opening up investing opportunities in the biotech sector over the past year. Consequently, this hot space for investments had a good run on the bourses during this period.

Notably, the world has now witnessed another grim milestone in the coronavirus outbreak as the number of confirmed cases has crossed the 100-million mark, according to Johns Hopkins University data. Going by the latest World Bank figures, considering the world population of about 7.67 billion, the global case numbers are signaling that about one in every 76 people has now had the coronavirus infection, as mentioned in a CNN report. It seems like the mutations have accelerated the spread of the virus.

The United States has also sadly crossed another glaring mark of more than 25 million coronavirus cases, with the death toll surpassing 400,000. Raising worries, health experts are "extremely" concerned about the new coronavirus variants that have been discovered in the United States, per a CNN report.

Buoying optimism, Moderna (MRNA) recently informed that its COVID-19 vaccine helped develop antibodies that neutralized coronavirus variants, which were first detected in the United Kingdom and South Africa, per a CNN report.

Novavax (NVAX) has also recently announced very encouraging updates on its protein-based COVID-19 vaccine candidate NVX-CoV2373. Per management, the vaccine candidate met the primary endpoint, delivering an efficacy of 89.3%, in its Phase 3 clinical trial conducted in the United Kingdom.

Let’s take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.

1 2 3
View single page >> |

Disclaimer: Neither Zacks Investment Research, Inc. nor its Information Providers can guarantee the accuracy, completeness, timeliness, or correct sequencing of any of the Information on the Web ...

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.